Understanding the pathogenesis of abdominal aortic aneurysms

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 9, 2015, Pages 975-987

  Kuivaniemi, Helena ^a,b,c   Ryer, Evan J ^d   Elmore, James R ^d   Tromp, Gerard ^a,c  

^a WEIS CENTER FOR RESEARCH   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d GEISINGER HEALTH SYSTEM   (United States)

Author keywords

animal models; doxycycline; embryologic origin; epigenetics; extracellular matrix; genetic susceptibility; inflammation; matrix metalloproteinases; risk factors; smoking

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL MODEL; AORTA ANEURYSM; CARDIOVASCULAR RISK; CLINICAL FEATURE; EPIGENETICS; GENETIC DISORDER; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; THORACIC AORTA; ANIMAL; AORTA; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODEL; EMBRYOLOGY;

ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84940565854     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1074861     Document Type: Review

References (113)

1. Filardo G, Powell JT, Martinez MA, Ballard DJ. Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev 2015; 2: CD001835
2. Larsson E, Granath F, Swedenborg J, Hultgren R. More patients are treated for nonruptured abdominal aortic aneurysms, but the proportion of women remains unchanged. J Vasc Surg 2008;48(4):802-7
3. Olsson C, Thelin S, Stahle E, et al. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation 2006;114(24):2611-18
4. Kent KC. Clinical practice. Abdominal aortic aneurysms. N Engl J Med 2014; 371(22):2101-8
5. Jongkind V, Yeung KK, Akkersdijk GJ, et al. Juxtarenal aortic aneurysm repair. J Vasc Surg 2010;52(3):760-7
6. Tromp G, Kuivaniemi H, Hinterseher I, Carey DJ. Novel genetic mechanisms for aortic aneurysms. Curr Atheroscler Rep 2010;12(4):259-66
7. Wiegreffe C, Christ B, Huang R, Scaal M. Remodeling of aortic smooth muscle during avian embryonic development. Dev Dyn 2009;238(3):624-31
8. Ruddy JM, Jones JA, Ikonomidis JS. Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of embryologic origin. Prog Cardiovasc Dis 2013;56(1):68-73
9. Steed MM, Tyagi SC. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxidants & redox signaling 2011;15(7):1927-43
10. Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. BioFactors 2009;35(2):120-9
11. Dalton ML, Gadson PF Jr, Wrenn RW, Rosenquist TH. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J 1997;11(8):703-11
12. Bruemmer D, Daugherty A, Lu H, Rateri DL. Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms. Ann N Y Acad Sci 2011;1245:7-10
13. Rateri DL, Howatt DA, Moorleghen JJ, et al. Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J PAthol 2011;179(3):1542-8
14. Gadson PF Jr, Dalton ML, Patterson E, et al. Differential response of mesodermand neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes. Exp Cell Res 1997; 230(2):169-80
15. Ruddy JM, Jones JA, Spinale FG, Ikonomidis JS. Regional heterogeneity within the aorta: relevance to aneurysm disease. J Thorac Cardiovasc Surg 2008; 136(5):1123-30
16. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ Res 1969; 25(6):677-86
17. Chaer RA, Vasoncelos R, Marone LK, et al. Synchronous and metachronous thoracic aneurysms in patients with abdominal aortic aneurysms. J Vasc Surg 2012;56(5):1261-5
18. Kuivaniemi H, Platsoucas CD, Tilson MD 3rd. Aortic aneurysms: an immune disease with a strong genetic component. Circulation 2008;117(2): 242-52
19. Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010; 52(3):539-48
20. Svensjö S, Björck M, Gurtelschmid M, et al. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011;124(10): 1118-23
21. Sakalihasan N, Defraigne JO, Kerstenne MA, et al. Family members of patients with abdominal aortic aneurysms are at increased risk for aneurysms: analysis of 618 probands and their families from the Liege AAA Family Study. Ann Vasc Surg 2014;28(4):787-97
22. Joergensen TM, Houlind K, Green A, Lindholt JS. Abdominal aortic diameter is increased in males with a family history of abdominal aortic aneurysms: results from the Danish VIVA-trial. Eur J Vasc Endovasc Surg 2014;48(6):669-75
23. Akai A, Watanabe Y, Hoshina K, et al. Family history of aortic aneurysm is an independent risk factor for more rapid growth of small abdominal aortic aneurysms in Japan. J Vasc Surg 2015;61(2):287-90
24. Conrad MF, Crawford RS, Pedraza JD, et al. Long-term durability of open abdominal aortic aneurysm repair. J Vasc Surg 2007;46(4):669-75
25. Hertzer NR, Mascha EJ, Karafa MT, et al. Open infrarenal abdominal aortic aneurysm repair: the Cleveland Clinic experience from 1989 to 1998. J Vasc Surg 2002;35(6): 1145-54
26. Chaikof EL, Brewster DC, Dalman RL, et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg 2009;50(4 Suppl):S2-49
27. Brown LC, Powell JT, Thompson SG, et al. The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy. Health Technol Assess 2012;16(9):1-218
28. Kurosawa K, Matsumura JS, Yamanouchi D. Current status of medical treatment for abdominal aortic aneurysm. Circulation Journal 2013;77(12):2860-6
29. Meijer CA, Stijnen T, Wasser MN, et al. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann Intern Med 2013;159(12):815-23
30. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006;368(9536):659-65
31. Sweeting MJ, Thompson SG, Brown LC, et al. Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J Vasc Surg 2010;52(1):1-4
32. Liao JK. Effects of statins on 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 2005;96(5A): 24F-33F
33. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118
34. Sweeting MJ, Thompson SG, Brown LC, et al. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012;99(5):655-65
35. Takagi H, Yamamoto H, Iwata K, et al. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg 2012; 44(3):287-92
36. Wemmelund H, Hogh A, Hundborg HH, et al. Statin use and rupture of abdominal aortic aneurysm. Br J Surg 2014;101(8): 966-75
37. Boddy AM, Lenk GM, Lillvis JH, et al. Basic research studies to understand aneurysm disease. Drug News Perspect 2008;21(3):142-8
38. Kuivaniemi H, Tromp G, Carey DJ, Elmore JR. The Molecular Biology and Genetics of Aneurysms. In: Homeister JW, Willis MS, editors. Molecular and translational vascular medicine. Springer Science+Business Media: NY; 2012. p. 3-33
39. Kuivaniemi H, Ryer EJ, Yoon HR, et al. Genetic risk factors for abdominal aortic aneurysms (AAA). In: Bennington EH, editor. Horizons in World Cardiovascular Research. Nova Science Publishers; Hauppauge, NY: 2015
40. Hinterseher I, Gabel G, Corvinus F, et al. Presence of Borrelia burgdorferi sensu lato antibodies in the serum of patients with abdominal aortic aneurysms. Eur J Clin Microbiol & Infec Dis 2011;31(5):781-9
41. Dale MA, Ruhlman MK, Baxter BT. Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy. Arterioscler Thromb Vasc Biol 2015;35(8):1746-55
42. Estrelinha M, Hinterseher I, Kuivaniemi H. Gene expression studies in human abdominal aortic aneurysm. Rev Vasc Med 2014;2(3):77-82
43. Nischan J, Lenk GM, Boddy AM, et al. Abdominal aortic aneurysms- a complex genetic disease. In: Laurent A, Morel E, editors. Aneurysms: types, risks, formation and treatment. Nova Science Publishers, Inc; Hauppage, NY: 2010. p. 35-93
44. Tromp G, Kuivaniemi H. Developments in genomics to improve understanding, diagnosis and management of aneurysms and peripheral artery disease. Eur J Vasc Endovasc Surg 2009;38(6):676-82
45. Nischan J, Gatalica Z, Curtis M, et al. Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms. Circ Cardiovasc Genet 2009;2(6):565-72
46. Hinterseher I, Erdman R, Elmore JR, et al. Novel pathways in the pathobiology of human abdominal aortic aneurysms. Pathobiology 2013;80(1):1-10
47. Biros E, Gabel G, Moran CS, et al. Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease. Oncotarget 2015;6(15): 12984-96
48. Lenk GM, Tromp G, Weinsheimer S, et al. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007;8(1):237
49. Biros E, Moran CS, Rush CM, et al. Differential gene expression in the proximal neck of human abdominal aortic aneurysm. Atherosclerosis 2014;233(1):211-18
50. Choke E, Cockerill GW, Laing K, et al. Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2009;37(3):305-10
51. Courtois A, Nusgens BV, Hustinx R, et al. Gene expression study in positron emission tomography-positive abdominal aortic aneurysms identifies CCL18 as a potential biomarker for rupture risk. Mol Med 2015; 20(1):697-706
52. Giusti B, Rossi L, Lapini I, et al. Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2009;38(1): 104-12
53. Hinterseher I, Schworer CM, Lillvis JH, et al. Immunohistochemical analysis of the natural killer cell cytotoxicity pathway in human abdominal aortic aneurysms. Int J Mol Sci 2015;16:11196-212
54. Pahl MC, Erdman R, Kuivaniemi H, et al. Transcriptional (ChIP-Chip) analysis of ELF1, ETS2, RUNX1 and STAT5 in human abdominal aortic aneurysm. Int J Mol Sci 2015;16:11229-58
55. Pahl MC, Derr K, Gabel G, et al. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med Genomics 2012;5(1):25
56. Maegdefessel L, Azuma J, Toh R, et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012;122(2): 497-506
57. Maegdefessel L, Spin JM, Raaz U, et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat Commun 2014;5:5214
58. Zampetaki A, Attia R, Mayr U, et al. Role of miR-195 in aortic aneurysmal disease. Circ Res 2014;115(10):857-66
59. Martinez-Pinna R, Burillo E, Madrigal-Matute J, et al. Label-free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients. Proteomics. Clin Appl 2014;8(7-8):626-30
60. Martinez-Pinna R, Gonzalez de Peredo A, Monsarrat B, et al. Label-free quantitative proteomic analysis of human plasma-derived microvesicles to find protein signatures of abdominal aortic aneurysms. Proteomics. Clin Appl 2014;8(7-8):620-5
61. Martinez-Pinna R, Ramos-Mozo P, Madrigal-Matute J, et al. Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2011;31(4):935-43
62. Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R, et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011;31(12):3011-19
63. Airhart N, Brownstein BH, Cobb JP, et al. Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg 2014;60(4): 1033-41
64. Boytard L, Spear R, Chinetti-Gbaguidi G, et al. Role of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans. Arterioscler Thromb Vasc Biol 2013;33(2): 431-8
65. Ryer EJ, Garvin RP, Schworer CM, et al. Proinflammatory role of stem cells in abdominal aortic aneurysms. J Vasc Surg 2014;S0741-5214
66. Blose KJ, Ennis TL, Arif B, et al. Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression. Regen Med 2014;9(6), 733-741
67. Davis JP, Salmon M, Pope NH, et al. Attenuation of aortic aneurysms with stem cells from different genders. J Surg Res 2015; Epub ahead of print
68. Norman PE, Curci JA. Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysm. Arterioscler Thromb Vasc Biol 2013;33(7)
69. Lemaitre V, Dabo AJ, D'Armiento J. Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci 2011;123(2):542-9
70. Chen QW, Edvinsson L, Xu CB. Cigarette smoke extract promotes human vascular smooth muscle cell proliferation and survival through ERK1/2- and NF-kappaB-dependent pathways. Sci World J 2010;10:2139-56
71. Maegdefessel L, Azuma J, Toh R, et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med 2012;4(122):122ra122
72. Wang S, Zhang C, Zhang M, et al. Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med 2012;18(6):902-10
73. Jin J, Arif B, Garcia-Fernandez F, et al. Novel mechanism of aortic aneurysm development in mice associated with smoking and leukocytes. Arterioscler Thromb Vasc Biol 2012;32(12):2901-9
74. Wang Y, Krishna S, Golledge J. The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis 2013;226(1):29-39
75. Liu Z, Morgan S, Ren J, et al. Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm. Circ Res 2015;117(2):129-41
76. Davis FM, Rateri DL, Balakrishnan A, et al. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms. Arterioscler Thromb Vasc Biol 2015;35(1):155-62
77. Sawada H, Hao H, Naito Y, et al. Aortic iron overload with oxidative stress and inflammation in human and murine abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2015;35(6):1507-14
78. Raaz U, Zöllner AM, Schellinger IN, et al. Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development. Circulation 2015;131(20): 1783-95
79. Tromp G, Kuivaniemi H. How does one study genetic risk factors in a complex disease such as aneurysms? In: Sakalihasan N, Kuivaniemi H, Michel J-B, editors. Aortic aneurysms: new insights into an old problem. Les Editions de l'Universite de Liège, Liège, Belgium, 2008. p. 115-44
80. Wahlgren CM, Larsson E, Magnusson PK, et al. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J Vasc Surg 2010; 51(1): 3-7
81. Greco G, Egorova NN, Gelijns AC, et al. Development of a novel scoring tool for the identification of large >/=5 cm abdominal aortic aneurysms. Ann Surg 2010;252(4): 675-82
82. Smelser DT, Tromp G, Elmore JR, et al. Population risk factor estimates for abdominal aortic aneurysm from electronic medical records: a case control study. BMC Cardiovasc Disord 2014;14:174
83. Hinterseher I, Tromp G, Kuivaniemi H. Genes and abdominal aortic aneurysm. Ann Vasc Surg 2011;25(3):388-412
84. Shibamura H, Olson JM, van Vlijmen-Van Keulen C, et al. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 2004;109(17):2103-8
85. Van Vlijmen-Van Keulen CJ, Rauwerda JA, Pals G. Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3. Eur J Vasc Endovasc Surg 2005;30(1):29-35
86. Bradley DT, Hughes AE, Badger SA, et al. A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet 2013;6(5):498-504
87. Bown MJ, Jones GT, Harrison SC, et al. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet 2011;89(5):619-27
88. Gretarsdottir S, Baas AF, Thorleifsson G, et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010;42(8):692-7
89. Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008; 40(2):217-24
90. Harrison SC, Smith AJ, Jones GT, et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J 2013;34(48):3707-16
91. Consortium IG. Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. Lancet Diabetes Endocrin 2015;3(4):243-53
92. Johnston WF, Salmon M, Su G, et al. Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2013;33(2): 294-304
93. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013;110(9):3507-12
94. van de Luijtgaarden KM, Bastos Goncalves F, Hoeks SE, et al. Lower atherosclerotic burden in familial abdominal aortic aneurysm. J Vasc Surg 2014;59(3): 589-93
95. van de Luijtgaarden KM, Bastos Goncalves F, Hoeks SE, et al. Familial abdominal aortic aneurysm is associated with more complications after endovascular aneurysm repair. J Vasc Surg 2014;59(2):275-82
96. Ryer EJ, Garvin RP, Thomas B, et al. Patients with familial abdominal aortic aneurysms are at increased risk for endoleak and secondary intervention following elective endovascular aneurysm repair. J Vasc Surg 2015; Epub ahead of print
97. Brown CR, Greenberg RK, Wong S, et al. Family history of aortic disease predicts disease patterns and progression and is a significant influence on management strategies for patients and their relatives. J Vasc Surg 2013;58(3): 573-81
98. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13(7):484-92
99. Napoli C, Crudele V, Soricelli A, et al. Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms? Circulation 2012; 125(19):2363-73
100. Breitling LP. Current genetics and epigenetics of smoking/tobacco-related cardiovascular disease. Arterioscler Thromb Vasc Biol 2013;33(7):1468-72
101. Toghill BJ, Saratzis A, Harrison SC, et al. The potential role of DNA methylation in the pathogenesis of abdominal aortic aneurysm. Atherosclerosis 2015;241(1): 121-9
102. Ryer EJ, Ronning KE, Erdman R, et al. The potential role of DNA methylation in abdominal aortic aneurysms. Int J Mol Sci 2015;16:11259-75
103. Obata Y, Furusawa Y, Hase K. Epigenetic modifications of the immune system in health and disease. Immunol Cell Biol 2015;93(3):226-32
104. Suzuki T, Distante A, Zizza A, et al. Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection. Eur Heart J 2008;29(11): 1439-45
105. Lindeman JH, Rabelink TJ, van Bockel JH. Immunosuppression and the abdominal aortic aneurysm: doctor jekyll or mister hyde? Circulation 2011;124(18):e463-5
106. Schrodi SJ, Mukherjee S, Shan Y, et al. Genetic-based prediction of disease traits: prediction is very difficult, especially about the future. Front Genet 2014;5:162
107. Ritchie MD, de Andrade M, Kuivaniemi H. The foundation of precision medicine: integration of electronic health records with genomics through basic, clinical, and translational research. Front Genet 2015;6:104
108. Trollope A, Moxon JV, Moran CS, Golledge J. Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol 2011;20(2):114-23
109. Jones GT, Bown MJ, Gretarsdottir S, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet 2013;22(14):2941-7
110. Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012;60(8):722-9
111. Jones GT, Thompson AR, van Bockxmeer FM, et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 2008;28(4):764-70
112. Biros E, Norman PE, Jones GT, et al. Meta-analysis of the association between single nucleotide polymorphisms in TGF-beta receptor genes and abdominal aortic aneurysm. Atherosclerosis 2011; 219(1):218-23
113. McColgan P, Peck GE, Greenhalgh RM, Sharma P. The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16,700 patients. Int Surg 2009;94(4):350-8